What is HEM stock price?

HEM (Hemostemix Inc) is currently trading at $0.06 on the Toronto Stock Exchange (TSX).

Stocks/TSX-V/HEM

Hemostemix Inc (HEM : TSX-V)

Common Stock

$0.06

CAD

+0.00 (%)

Last updated: 2026-09-30

Follow HEM

HEM

Hemostemix Inc

Source:

WealthAwesome

↓ $0.01 (-14.29%)

30 day period

Performance

1 Day

+0.00%

1 Week

-7.69%

1 Month

-20.00%

YTD

-33.33%

Key Statistics

Market Cap

$12.69M

52W High

$0.13

52W Low

$0.04

P/E Ratio

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.67

Dividend Yield

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

Date	Open	High	Low	Close	Adj Close	Volume
9/30/2026	$0.06	$0.06	$0.06	$0.06	$0.06	1,100
9/29/2026	$0.06	$0.06	$0.06	$0.06	$0.06	1,000
9/28/2026	$0.06	$0.06	$0.06	$0.06	$0.06	7,077
9/24/2026	$0.06	$0.07	$0.06	$0.07	$0.07	10,000
9/23/2026	$0.07	$0.07	$0.06	$0.07	$0.07	269,482
9/22/2026	$0.07	$0.07	$0.07	$0.07	$0.07	2,577
9/21/2026	$0.07	$0.07	$0.07	$0.07	$0.07	50,001
9/18/2026	$0.07	$0.07	$0.07	$0.07	$0.07	4,000
9/17/2026	$0.07	$0.07	$0.07	$0.07	$0.07	14,077
9/15/2026	$0.07	$0.07	$0.07	$0.07	$0.07	2,023

Analyst Price Targets

Based on analyst covering HEM · as of Sep 17, 2026

📈

Wall Street analysts forecast HEM stock price to rise 1500.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1500.0% Upside

Current Price

C$0.06

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%

30-Day Vol

84.1%

Annualized

90-Day Vol

111.5%

Annualized

Trend (90d)

+36.5%

Annualized drift

90d Mean

C$0.07

Expected price

Horizon	Expected	68% Range (1σ)	95% Range (2σ)
30 trading days	C$0.06	C$0.05 – C$0.08	C$0.04 – C$0.11
60 trading days	C$0.07	C$0.04 – C$0.10	C$0.03 – C$0.15
90 trading days	C$0.07	C$0.04 – C$0.11	C$0.03 – C$0.19

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Hemostemix Inc

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Financials

Revenue (TTM): $0
EBITDA: $-5.06M
Profit Margin: 0.00%
ROE (TTM): 0.00%
EPS (Diluted): -0.03
Book Value: -0.03

Classification

Sector: Health Care
Industry: Biotechnology
Group: Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Explore More

Stock Screener TSX Stocks TSXV Stocks

Common Questions About HEM

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →

Ticker	Name	Price	1D
DELX	DelphX Capital Markets Inc	$0.01	+50.00%
SAT	Asian Television Network International Ltd	$0.05	+42.86%
TELO	Telo Genomics Corp	$0.05	+42.86%
AME	Abacus Mining and Exploration Corp	$0.02	+33.33%
SNV	Sonoro Energy Ltd	$0.02	+33.33%
TRAN	Clean Energy Transition Inc.	$0.04	+33.33%
INFI	Infinitum Copper Corp	$0.21	+31.25%
SFR	Sandfire Resources America Inc	$0.30	+27.08%

HEM.V news timeline

15 articles covering HEM.V, most recent first

Latest

What's Going On With Hemostemix Inc Stock Thursday?

Sep 10, 2026•Stocks

CIBC Investor's Edge